Rights and permissions
About this article
Cite this article
Daclizumab seems to have a renal-sparing effect in patients undergoing liver transplantation. Inpharma Wkly. 1243, 14 (2000). https://doi.org/10.2165/00128413-200012430-00034
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200012430-00034